Preliminary results of a Neoadjuvant combo-immunotherapy with ipilimumab and nivolumab in locally advanced or limited metastatic melanoma

被引：0
|
作者：
Ferrucci, Pier Francesco [1 ]
Pala, Laura [1 ]
Conforti, Fabio [1 ]
Nezi, Luigi [2 ]
Manzo, Teresa [2 ]
Cocorocchio, Emilia [1 ]
机构：
[1] European Inst Oncol, Melanoma Unit, Milan, Italy
[2] European Inst Oncol, Dept Expt Oncol, Milan, Italy
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant combination immunotherapy with ipilimumab (3 mg/kg or 10mg/kg) and high dose IFN-a2b in locally/regionally advanced melanoma.
    Tarhini, Ahmad A.
    Rahman, Zahra
    Lin, Yan
    Vallabhaneni, Priyanka
    Tawbi, Hussein Abdul-Hassan
    Gnan, Andrew
    McFadden, Amanda
    Rose, Amy
    Pruckner, Chelsea
    Wilson, Melissa
    Pingpank, James F.
    Holtzman, Matthew Peter
    Ferris, Robert L.
    Rao, Uma N. M.
    Kirkwood, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
    Tarhini, Ahmad A.
    Hanayneh, Wissam B.
    Powers, John J.
    Segura, Carlos M. Moran
    Conejo-Garcia, Jose R.
    Lam, Cesar A.
    Hakam, Ardeshir
    Hoffman, Mitchel S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] SECOMBIT (sequential combo immuno and target therapy study): A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with metastatic melanoma and BRAF mutation.
    Ascierto, Paolo Antonio
    Dummer, Reinhard
    Melero, Ignacio
    Palmieri, Giuseppe
    Giannarelli, Diana
    Abrami, Elena
    Curvietto, Marcello
    Simeone, Ester
    Grimaldi, Antonio Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma
    Sundahl, Nora
    Seremet, Teofila
    Van Dorpe, Jo
    Neyns, Bart
    Ferdinande, Liesbeth
    Meireson, Annabel
    Brochez, Lieve
    Kruse, Vibeke
    Ost, Piet
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (04): : 828 - 835
  • [45] Real-world use of ipilimumab and nivolumab monotherapy or in combination in patients with advanced melanoma: results from a retrospective chart review
    Tarhini, A.
    Macahilig, C.
    Atzinger, C.
    Gupte-Singh, K.
    Solem, C.
    Rao, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC MELANOMA: PRELIMINARY RESULTS FROM REAL WORLD
    Cardoso Borges, F.
    Murteira, R.
    Ramos, C.
    Soares, P.
    Ferreira, M.
    Furtado, C.
    Miranda, A.
    Alves da Costa, F.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [47] Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors
    Apolo, Andrea B.
    Girardi, Daniel M.
    Niglio, Scot A.
    Nadal, Rosa
    Kydd, Andre R.
    Simon, Nicholas
    Ley, Lisa
    Cordes, Lisa M.
    Chandran, Elias
    Steinberg, Seth M.
    Lee, Sunmin
    Lee, Min-Jung
    Rastogi, Shraddha
    Sato, Nahoko
    Cao, Liang
    Banday, A. Rouf
    Boudjadi, Salah
    Merino, Maria J.
    Toubaji, Antoun
    Akbulut, Dilara
    Redd, Bernadette
    Bagheri, Hadi
    Costello, Rene
    Gurram, Sandeep
    Agarwal, Piyush K.
    Chalfin, Heather J.
    Valera, Vladimir
    Streicher, Howard
    Wright, John Joseph
    Sharon, Elad
    Figg, William D.
    Parnes, Howard L.
    Gulley, James L.
    Saraiya, Biren
    Pal, Sumanta K.
    Quinn, David
    Stein, Mark N.
    Lara, Primo N.
    Bottaro, Donald P.
    Mortazavi, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (25)
  • [48] Long-term follow-up results of ipilimumab and nivolumab for the treatment of mismatch repair deficient locally advanced rectal cancer
    Trotier, Danny
    Uboha, Nataliya Volodymyrivna
    Matkowskyj, Kristina A.
    Zhang, Wei
    Kratz, Jeremy D.
    Carchman, Evie
    Lawson, Eilse
    Sanger, Cristina
    Heise, Charles
    Lubner, Sam Joseph
    Patel, Monica Arun
    LoConte, Noelle K.
    Bassetti, Michael F.
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Development of autoimmune nephritis requiring dialysis, atypical hemolytic uramic syndrome (aHUS) and hypersplenism during double immunotherapy with nivolumab/ipilimumab in metastatic malignant melanoma
    Adam, L.
    Yordanova, K.
    Preiss, M. M.
    Vogt, T.
    Pfoehler, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 56 - 56
  • [50] Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status
    Li, Yingjie
    Tan, Luxin
    Chen, Nan
    Liu, Xinzhi
    Liang, Fei
    Yao, Yunfeng
    Zhang, Xiaoyan
    Wu, Aiwen
    DISEASES OF THE COLON & RECTUM, 2024, 67 (11) : 1413 - 1422
12345